BRAF-KIAA1549 Fusion Transcripts Are Less Frequent in Pilocytic Astrocytomas Diagnosed in Adults
Overview
Authors
Affiliations
Aim: Duplication of 7q34 resulting in generation of BRAF-KIAA1549 fusion transcripts is a characteristic event in pilocytic astrocytoma that may also aid distinction from diffuse astrocytic tumours. As data on BRAF-KIAA1549 fusion transcript status remain mainly limited to children, we aimed to examine the diagnostic value of BRAF-KIAA1549 fusion transcripts across all age groups.
Methods: BRAF-KIAA1549 fusion transcript status was examined using reverse transcription polymerase chain reaction on formalin-fixed paraffin-embedded samples of 105 primary pilocytic astrocytomas [median patient age: 17 years (1-74 years)].
Results: Informative results (distinct wildtype BRAF bands detectable) were obtained in 105/124 cases (85%). Fusion transcripts were detected in 53 of cases (51%). They were more often encountered in tumours of infratentorial location [42/67 (63%) vs. 11/38 (29%)] and comprised KIAA1549-Ex16_BRAF-Ex9 (32 cases), KIAA1549-Ex15_BRAF-Ex9 (14 cases) and KIAA1549-Ex16_BRAF-Ex11 (seven cases). Fusion transcripts were present in 79% of tumours diagnosed in the first decade of life, but only in 51% of patients aged 11-20 years, 42% of patients aged 21-30 years, 30% of patients aged 31-40 years and 7% of patients older than 40 years. On multivariate logistic regression analysis, the association of fusion transcript status and age was confirmed adjusting for tumour location (P = 0.006).
Conclusions: The frequency of BRAF-KIAA1549 fusion transcripts is significantly lower in adult patients with pilocytic astrocytoma, weakening the sensitivity of this specific diagnostic marker in that age group.
A bibliometric analysis of research trends and hotspots of pilocytic astrocytoma from 2004 to 2023.
Liang Q, Wu Z, Zhu S, Du Y, Cheng Z, Chen Y Neurosurg Rev. 2024; 48(1):3.
PMID: 39724457 PMC: 11671565. DOI: 10.1007/s10143-024-03139-9.
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.
Wang W, Lian B, Xu C, Wang Q, Li Z, Zheng N Innovation (Camb). 2024; 5(6):100661.
PMID: 39529955 PMC: 11551471. DOI: 10.1016/j.xinn.2024.100661.
Specifics of spinal neuropathology in the molecular age.
Kresbach C, Hack K, Ricklefs F, Schuller U Neurooncol Adv. 2024; 6(Suppl 3):iii3-iii12.
PMID: 39430396 PMC: 11485660. DOI: 10.1093/noajnl/vdad127.
Roberto K, Keith J, Levine A, Pirouzmand F, Soliman H, Lim-Fat M JCO Precis Oncol. 2024; 8:e2400174.
PMID: 38905571 PMC: 11371098. DOI: 10.1200/PO.24.00174.
Francis C, Kanaya K, Nagamine K, Goto T, Horiuchi T, Ohaegbulam S Surg Neurol Int. 2024; 15:90.
PMID: 38628526 PMC: 11021065. DOI: 10.25259/SNI_978_2023.